Brief: Ceapro Reports Q2 Shr $0.00
28/08/2018 14:21
Aug 28 (Reuters) - Ceapro Inc CZO.V :
* CEAPRO REPORTS 2018 SECOND QUARTER AND SIX-MONTH FINANCIAL
RESULTS AND OPERATIONAL HIGHLIGHTS
* QUARTERLY LOSS PER SHARE C$0.00
* Q2 SALES C$2.7 MILLION VERSUS C$3.2 MILLION
Source text for Eikon: ID:nGNXcdQNGR
Further company coverage: CZO.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ceapro
See all newsBrief: Aeterna Zentaris Announces Details Regarding Transaction with Ceapro
Brief: Ceapro Receives Final Court Approval For Merger With Aeterna Zentaris
Brief: Aeterna Zentaris And Ceapro Announce Merger Of Equals To Create Diversified Biopharmaceutical Company
Brief: Ceapro Inc. Reports 2023 Third Quarter And Nine-Month Financial Results And Operational Highlights
Brief: Ceapro Initiates Phase 1-2A Study Assessing Avenanthramides For Potential Applications In Inflammation Based Diseases